Segall Bryant & Hamill LLC acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 358,935 shares of the company's stock, valued at approximately $10,883,000. Segall Bryant & Hamill LLC owned approximately 0.17% of Bath & Body Works as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Golden State Wealth Management LLC lifted its holdings in shares of Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares during the last quarter. UMB Bank n.a. lifted its position in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after acquiring an additional 596 shares during the period. EverSource Wealth Advisors LLC lifted its position in Bath & Body Works by 109.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock worth $63,000 after acquiring an additional 852 shares during the period. Ancora Advisors LLC acquired a new stake in Bath & Body Works during the 4th quarter worth approximately $67,000. Finally, TD Private Client Wealth LLC lifted its position in Bath & Body Works by 34.9% during the 4th quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock worth $89,000 after acquiring an additional 593 shares during the period. Hedge funds and other institutional investors own 95.14% of the company's stock.
Bath & Body Works Price Performance
Shares of NYSE BBWI traded up $0.08 during midday trading on Friday, hitting $31.79. 4,055,565 shares of the company's stock were exchanged, compared to its average volume of 5,262,039. The stock's 50 day moving average price is $30.16 and its 200-day moving average price is $32.25. The firm has a market cap of $6.73 billion, a P/E ratio of 8.48, a PEG ratio of 1.07 and a beta of 1.72. Bath & Body Works, Inc. has a twelve month low of $24.94 and a twelve month high of $41.87.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The firm had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The firm's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.38 earnings per share. On average, analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were given a dividend of $0.20 per share. The ex-dividend date was Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.52%. Bath & Body Works's dividend payout ratio (DPR) is presently 21.33%.
Analyst Ratings Changes
A number of brokerages have recently issued reports on BBWI. Barclays cut their target price on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research note on Friday, May 30th. Citigroup upped their price target on Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a report on Tuesday, May 20th. Wells Fargo & Company upped their price target on Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, May 14th. Raymond James Financial lowered their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a report on Thursday, April 17th. Finally, UBS Group lifted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a research report on Tuesday, May 20th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works has a consensus rating of "Moderate Buy" and an average target price of $42.00.
Check Out Our Latest Research Report on BBWI
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
